{"id":"NCT01342094","sponsor":"Santen Pharmaceutical Co., Ltd.","briefTitle":"DE-111 Against Timolol Ophthalmic Solution 0.5%","officialTitle":"A Double-masked Study of DE-111 Ophthalmic Solution Versus Timolol Ophthalmic Solution 0.5% in Patients With Primary Open Angle Glaucoma or Ocular Hypertension - Phase 3, Confirmatory Study -","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-05","primaryCompletion":"2012-09","completion":null,"firstPosted":"2011-04-26","resultsPosted":"2015-05-15","lastUpdate":"2015-07-10"},"enrollment":166,"design":{"allocation":null,"model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Open Angle Glaucoma","Ocular Hypertension"],"interventions":[{"type":"DRUG","name":"DE-111 ophthalmic solution","otherNames":[]},{"type":"DRUG","name":"Timolol ophthalmic solution 0.5%","otherNames":[]},{"type":"DRUG","name":"Placebo ophthalmic solution","otherNames":[]}],"arms":[{"label":"DE-111 ophthalmic solution","type":"EXPERIMENTAL"},{"label":"Timolol ophthalmic solution 0.5%","type":"ACTIVE_COMPARATOR"}],"summary":"DE-111 ophthalmic solution will be evaluated for superiority in comparison with Timolol ophthalmic solution 0.5%, in IOP(intraocular pressure ) -lowering effect in primary open-angle glaucoma or ocular hypertension patients, in a multicenter, randomized, double-masked, parallel-group comparison study. Safety will be compared and evaluated as well.","primaryOutcome":{"measure":"Change From Baseline in Mean Diurnal IOP (Intraocular Pressure) at End of Study","timeFrame":"Week 0(Baseline) and Week 4(End of Study)","effectByArm":[{"arm":"DE-111","deltaMin":-3.2,"sd":2.1},{"arm":"Timolol","deltaMin":-1.7,"sd":2.1}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":2},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":82},"commonTop":["Ocular hyperaemia","Conjunctival hyperaemia"]}}